by Ingrid Niesman | Mar 2, 2017 | conditions
Table of Contents 1. Introduction 2. Protein Sciences’ Zika Vaccine Candidate 3. BEVS Technology 4. Preclinical Studies Results 5. Toxicology Studies 6. Funding and Consortium Partners 7. Current Influenza Vaccine Production 8. Clinical Trial of National...
by MyBiosource Editorial Team | Mar 1, 2017 | outbreaks
Table of Contents 1. Introduction 2. Success of DNA-based Zika Virus Vaccine in Human Trials 3. Positive Clinical Data and Safety of Vaccine 4. Study Conducted as Low and High Dose Vaccine Groups 5. Phase 2 Trials in Puerto Rico 6. Monoclonal Antibody Therapies for...